Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

In response, the body prioritizes central blood volume by reducing circulation to the skin, which can result in a purple-red rash appearing on the cheeks and the bridge of the nose. Shaped ...

Parents are heartbroken as a beloved nappy rash cream - Metanium Nappy Rash Ointment - is discontinued. The product, known for its quick healing properties, has been a staple in changing bags for ...

Adult diaper rash can develop when wearing adult diapers, incontinence briefs, or pads. It typically begins as small, inflamed patches of irritated skin and progresses to larger patches of raised ...

However, as it progresses, it can cause symptoms such as itchy skin, pruritus, and a rash. Around 35.5 million adults in the United States live with kidney disease, but only about 10% know they ...

The primary symptom of papular eczema is a skin rash made of small lumps and bumps that resemble acne. The rash can appear anywhere on your body but is most likely to appear on your stomach ...

Skin biopsy: To do this, your dermatologist removes a small sample from your rash, so that it can be examined under a microscope. Nail biopsy: If lichen planus may be affecting one or more of your ...

Rash during pregnancy is not uncommon, ranging from a relatively harmless heat rash to potentially life-threatening conditions like impetigo herpetiformis. These rashes may develop due to changes in ...

A rash is a generic term for an area of irritated skin. This irritation can take many forms, including redness, swelling, itching, and dryness. This is a rash that was once a hallmark sign of Graves' ...

Sanofi’s cancer immunotherapy Libtayo (cemiplimab) has a third US indication after the FDA approved it for certain untreated lung cancer patients. The approval in first-line lung cancer ...